Home>Topics>Stocks>GlaxoSmithKline PLC ADR

GlaxoSmithKline PLC ADR GSK

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
    1. Week In Review: GSK Ends China Bribery Investigation By Paying $489 Million Fine

      Headlines

      Sun, 21 Sep 2014

      doctors in China, GlaxoSmithKline (NYSE: GSK ) was ordered by a China court to pay a ..... billion RMB) is a record in China, though GSK is probably relieved it wasn't higher. In addition, Mark Reilly, head of GSK China's operations when the scandal broke

    2. China hands drugmaker GSK record $489 million fine for paying bribes

      Headlines

      Fri, 19 Sep 2014

      SHANGHAI/LONDON (Reuters) - China fined GlaxoSmithKline Plc a record 3 billion yuan ($489 million) on Friday for paying bribes to doctors to use its drugs, underlining the risks of doing business there while also ending a damaging chapter for the British drugmaker.

    3. UPDATE 4-China hands drugmaker GSK record $489 mln fine for paying bribes

      Headlines

      Fri, 19 Sep 2014

      * Former China head gets suspended sentence, to be deported

    4. It Takes Less Than 15 Minutes To Buy VVUS Shares!

      Headlines

      Fri, 19 Sep 2014

      By Rx Stocks : The FDA has approved new labeling for Stendra for use in as little as 15 minutes . Moreover, the marketing partner, Auxilium Pharmacueticals Inc. (NASDAQ: AUXL ), just recieved a takeover bid from Endo International (NASDAQ: ENDP ). Vivus Pharmaceuticals (NASDAQ: VVUS ) shares have

    5. EC clears Xultophy

      Headlines

      Fri, 19 Sep 2014

      insulin degludec ( Tresiba ) and liraglutide ( Victoza ). Novo plans to launch the product in Europe in 1H 2015. Related tickers: (NYSE: NVS ) (NYSE: LLY ) (NYSE: MRK ) (NYSE: SNY ) (NYSE: AZN ) (NYSE: GSK ) Post your comment!

    6. GSK to pay $488M penalty over Chinese bribes

      Headlines

      Fri, 19 Sep 2014

      GlaxoSmithKline (NYSE: GSK ) will pay a $488M fine after being found guilty ..... promote use of its medicines. Former head of GSK ’s China business, Mark Reilly, and four other senior Chinese GSK managers pleaded guilty to the charges, and

    7. GSK ex-China head Mark Reilly to be deported from China, won't face jail time - source

      Headlines

      Fri, 19 Sep 2014

      SHANGHAI, Sept 19 (Reuters) - Mark Reilly, the former China head of British drugmaker GlaxoSmithKline PLC, will be deported from China and will not face jail time in the country, according to a source with direct knowledge of the matter.

    8. China fines GSK $489 mln, jails executives -Xinhua

      Headlines

      Fri, 19 Sep 2014

      BEIJING, Sept 19 (Reuters) - China has fined British pharmaceuticals giant GlaxoSmithKline Plc 3 billion yuan ($488.8 million) for paying out bribes in what is a record penalty for China, state news agency Xinhua said on Friday.

    9. BRIEF- GSK says Chinese court finds unit guilty of bribing non-government personnel

      Headlines

      Fri, 19 Sep 2014

      * Changsha intermediate People's Court in Hunan Province, China ruled that GSK China Investment Co. Ltd (GSKCI) has, according to Chinese law, offered money or property to non-government personnel

    10. BRIEF-Valneva and GSK celebrate site dedication of vaccine facility in Texas

      Headlines

      Fri, 19 Sep 2014

      * Joins GlaxoSmithKline in celebrating site dedication of Texas A&M pandemic influenza vaccine facility in Texas

    « Prev12345Next »
    Content Partners